{
  "id": 3186899,
  "title": "Young startups miss out on biotech venture funding rebound, MassBio says",
  "url": "https://urgent.news/2026/08/25/young-startups-miss-out-on-biotech-venture-funding-rebound-massbio",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-25T04:01:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/massbio-industry-biotech-vc-ipo-funding-licensing/828621/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A new report found that the sizes of seed rounds and Series A financings for Massachusetts biotech startups are going in opposite directions, as funding slows for young companies with the “riskiest science.”",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}